DK254887D0 - Salve til behandling af hudsygdomme - Google Patents

Salve til behandling af hudsygdomme

Info

Publication number
DK254887D0
DK254887D0 DK254887A DK254887A DK254887D0 DK 254887 D0 DK254887 D0 DK 254887D0 DK 254887 A DK254887 A DK 254887A DK 254887 A DK254887 A DK 254887A DK 254887 D0 DK254887 D0 DK 254887D0
Authority
DK
Denmark
Prior art keywords
salvation
treatment
skin diseases
diseases
skin
Prior art date
Application number
DK254887A
Other languages
English (en)
Other versions
DK254887A (da
Inventor
Axel Roemer
Joerg Hager
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of DK254887D0 publication Critical patent/DK254887D0/da
Publication of DK254887A publication Critical patent/DK254887A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK254887A 1986-06-20 1987-05-19 Salve til behandling af hudsygdomme DK254887A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863620674 DE3620674A1 (de) 1986-06-20 1986-06-20 Salbe zur behandlung von hauterkrankungen

Publications (2)

Publication Number Publication Date
DK254887D0 true DK254887D0 (da) 1987-05-19
DK254887A DK254887A (da) 1987-12-21

Family

ID=6303316

Family Applications (1)

Application Number Title Priority Date Filing Date
DK254887A DK254887A (da) 1986-06-20 1987-05-19 Salve til behandling af hudsygdomme

Country Status (6)

Country Link
US (1) US4784994A (da)
EP (1) EP0249736A3 (da)
JP (1) JPS635022A (da)
DE (1) DE3620674A1 (da)
DK (1) DK254887A (da)
PT (1) PT84899B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
US5288734A (en) * 1988-10-29 1994-02-22 A. Nattermann & Cie Gmbh Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
US5340813A (en) * 1992-11-09 1994-08-23 Cell Therapeutics, Inc. Substituted aminoalkyl xanthine compounds
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
ES2145065T3 (es) * 1993-10-27 2000-07-01 Daiichi Seiyaku Co Preparacion granular.
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
EP0826371A4 (en) * 1995-04-27 2000-11-15 Akzo Nobel Nv PREPARATION OF EMEDASTIN FOR EXTERNAL USE
FR2740339B1 (fr) * 1995-10-26 1997-12-05 Oreal Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
HK1042082A1 (en) 1999-03-31 2002-08-02 Holmgren Arne Substrates for thioredoxin reductase
RU2003119140A (ru) * 2000-12-28 2004-12-27 Дайити Фармасьютикал Ко., Лтд. (JP) Эмульсионный препарат
DE10111052A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
DE10111050A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigenOrganismus ihre Wirkung entfaltet, zur Herstellung von kosmetischewn oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
DE10111049A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
DE10111054A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Stärkung der Barrierefunktion der Haut
US20030086916A1 (en) * 2001-10-12 2003-05-08 Goligorsky Michael S. Use of peroxynitrite scavengers or peroxynitrite formation inhibitors that do not diminish nitric oxide synthesis or activity to reverse or prevent premature vascular senescence
CN101843614B (zh) 2002-08-26 2013-05-22 S.L.A.制药有限公司 甲硝哒唑或其药学上可接受的衍生物的用途
WO2008146721A1 (ja) * 2007-05-25 2008-12-04 Santen Pharmaceutical Co., Ltd. 加齢黄斑変性の予防又は治療剤
IL184620A0 (en) * 2007-07-15 2008-01-20 Can Fite Biopharma Ltd Composition for the treatment of inflammation
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2707878C2 (de) * 1977-02-24 1986-01-30 Kali-Chemie Pharma Gmbh, 3000 Hannover Verwendung von Mono- und/oder Diglyceriden mittelkettiger Fettsäuren
US4525347A (en) * 1978-06-17 1985-06-25 Kowa Company Limited Antiinflammatory analgesic gelled ointment
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
CH655656B (da) * 1982-10-07 1986-05-15
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.
US4543251A (en) * 1983-12-09 1985-09-24 Toko Yakuhin Industry Co., Ltd. Gel preparations for external application
US4683242A (en) * 1985-10-28 1987-07-28 A. H. Robins Company, Incorporated Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters

Also Published As

Publication number Publication date
DK254887A (da) 1987-12-21
PT84899A (en) 1987-06-01
DE3620674A1 (de) 1987-12-23
JPS635022A (ja) 1988-01-11
US4784994A (en) 1988-11-15
EP0249736A2 (en) 1987-12-23
EP0249736A3 (en) 1989-03-29
PT84899B (pt) 1990-02-08

Similar Documents

Publication Publication Date Title
DK254887A (da) Salve til behandling af hudsygdomme
AU597635B2 (en) Treatment of diseases caused by retroviruses
DK333788A (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
ZW22687A1 (en) Treatment of diseases caused by viruses
DK545088D0 (da) Doseringsform til behandling af kardiovaskulaere sygdomme
PT88684A (pt) Metodo de tratamento fosfatidilico de doencas virais
ZA872359B (en) Treatment of diseases caused by retroviruses
DK617687A (da) Bestraalingsanordning til medicinsk behandling
DK360687D0 (da) Bestraalingsanordning til medicinsk behandling
DK489587D0 (da) Medicinsk hudpraeparat
DK83683A (da) Farmaceutiske praeparater til behandling af hud
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DK152587D0 (da) Bestraalingsanordning til medicinsk behandling
DK31386D0 (da) Behandling af proliferative hudsygdomme
DK10188D0 (da) Middel til behandling af virussygdomme
DK165664C (da) Psoralen-badpraeparat til behandling af psoriasis og andre hudsygdomme
DK24887D0 (da) Bestraalingsanordning til medicinsk behandling
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DK24987D0 (da) Bestraalingsanordning til medicinsk behandling
DK441987A (da) Farmaceutisk praeparat til behandling af cerebral ischaemi
DK24587A (da) Bestraalingsanordning til medicinsk behandling
DK650087D0 (da) Bestraalingsanordning til medicinsk behandling
DK639088D0 (da) Laegemiddel til behandling af iskaemiske hjertesygdomme
DK169087D0 (da) Praeparat til prophylakse og behandling af svinesygdomme
DK102488D0 (da) Praeparat til behandling af tandsygdomme

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment